Home/NRx Pharmaceuticals/Michael Abrams

MA

Michael Abrams

Chief Financial Officer

NRx Pharmaceuticals

Therapeutic Areas

Psychiatry Central Nervous System Mental Health Pain

NRx Pharmaceuticals Pipeline

Drug	Indication	Phase
NRX-101	Suicidal Bipolar Depression (Acute/Sub-Acute Suicidal Ideation & Behavior)	Phase 2
NRX-100	Suicidal Depression	NDA Submission
NRX-101 / NMDA Platform	Post-Traumatic Stress Disorder (PTSD)	Research

Leadership Team at NRx Pharmaceuticals

Jonathan C. Javitt

Founder, Chairman & Chief Scientist; Co-CEO HOPE Therapeutics

Chief Technology Officer

Founder of Angel Force USA (Collaborator)

View full NRx Pharmaceuticals profile